Literature DB >> 16794801

Intrahepatic segmental primary sclerosing cholangitis: report of a case.

Taku Matsumoto1, Tetsuo Ajiki, Ippei Matsumoto, Masahiro Tominaga, Hiroshige Hori, Yoshiyasu Mita, Tsunenori Fujita, Yasuhiro Fujino, Yasuyuki Suzuki, Yonson Ku, Yoshikazu Kuroda.   

Abstract

A 67-year-old woman was referred to our hospital for investigation of epigastric discomfort. Computed tomography (CT) showed dilatation of the intrahepatic bile duct in the left lobe of the liver, endoscopic cholangiography showed complete stenosis of the left main branch of intrahepatic bile duct, and CT during angiography showed decreased portal blood flow to segment 3 of the liver. Based on these findings, we suspected intrahepatic cholangiocarcinoma and performed left lobectomy of the liver. However, pathological examination revealed fibrosis and infiltration of inflammatory lymphoid cells around the stenotic bile duct and periportal area, without any evidence of malignancy. Since these findings were compatible with sclerosing cholangitis and the patient did not have a disorder that would cause secondary sclerosing cholangitis, the final diagnosis was primary sclerosing cholangitis (PSC). It is difficult to distinguish segmental PSC from cholangiocarcinoma; thus we think surgical resection is an appropriate therapeutic and diagnostic procedure for segmental intrahepatic bile duct stenosis.

Entities:  

Mesh:

Year:  2006        PMID: 16794801     DOI: 10.1007/s00595-006-3218-5

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  11 in total

1.  A localized primary sclerosing cholangitis preoperatively diagnosed as hilar cholangiocarcinoma; report of a case.

Authors:  Takahiro Kojima; Tatsuo Shimura; Minoru Takahashi; Norihiro Haga; Shinji Hashimoto; Takahiro Fukuda; Hiroyuki Kuwano
Journal:  Hepatogastroenterology       Date:  2004 Jul-Aug

Review 2.  Primary sclerosing cholangitis: updates in diagnosis and therapy.

Authors:  Piero Portincasa; Michele Vacca; Antonio Moschetta; Michele Petruzzelli; Giuseppe Palasciano; Karel J van Erpecum; Gerard P van Berge-Henegouwen
Journal:  World J Gastroenterol       Date:  2005-01-07       Impact factor: 5.742

3.  Effectiveness of radiation therapy after surgery for hilar cholangiocarcinoma.

Authors:  Noriaki Sagawa; Satoshi Kondo; Toshiaki Morikawa; Shunichi Okushiba; Hiroyuki Katoh
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

4.  Localized primary sclerosing cholangitis mimicking a cholecystectomy stricture relieved by an endoprosthesis.

Authors:  R Oren; E Goldin; N Harats; E Libson; D Shouval
Journal:  Postgrad Med J       Date:  1991-05       Impact factor: 2.401

5.  Localized sclerosing cholangitis?

Authors:  J Panés; J M Bordas; M Bruguera; M Cortés; J Rodés
Journal:  Endoscopy       Date:  1985-05       Impact factor: 10.093

6.  Sclerosing cholangitis of the bifurcation of the common hepatic duct.

Authors:  B Golematis; A Giannopoulos; D N Papchristou; D A Dreiling
Journal:  Am J Gastroenterol       Date:  1981-05       Impact factor: 10.864

7.  Unifocal stricture of the common bile duct in two children: a localized form of primary sclerosing cholangitis.

Authors:  E M Sokal; J Ville de Goyet; J P Buts; S Habets; S Gosseye; P Clapuyt; D Claus; J B Otte
Journal:  J Pediatr Gastroenterol Nutr       Date:  1990-08       Impact factor: 2.839

8.  A case of localized primary sclerosing cholangitis mimicking intrahepatic bile duct cancer.

Authors:  T Kawasaki; T Ueo; T Itani; M Shibatohge; J Mimura; H Komori; A Todo; T Okuno; M Kudo
Journal:  Hepatol Res       Date:  2001-06       Impact factor: 4.288

9.  Surgery for segmental primary sclerosing cholangitis.

Authors:  Takatsugu Yamamoto; Kazuhiro Hirohashi; Shoji Kubo; Tadashi Tsukamoto; Takahiro Uenishi; Taichi Shuto; Hiromu Tanaka; Hiroaki Kinoshita
Journal:  Hepatogastroenterology       Date:  2004 May-Jun

10.  Current concepts. Primary sclerosing cholangitis.

Authors:  N F LaRusso; R H Wiesner; J Ludwig; R L MacCarty
Journal:  N Engl J Med       Date:  1984-04-05       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.